Adjuvant chemotherapy or chemo-radiation in gallbladder cancer #ASCOGI25
🔎ACCELERATE phs-3 trial, poor accrual
👉RFS: 51.96 vs 43.99 mo
👉mOS: nr vs 34.5 mo
🧐 Addition of CRT to ChT doesn’t improve outcome, does not support RT in BTC...
@myESMO @EASLedu @ILCAnews #livertwitter
#ASCOGI25 #livertwitter